Erudio Healtherudio.com
Drug
Leuprolide trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying leuprolide: VA STARPORT. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 9 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| VA STARPORT NCT04787744 · VA Office of Research and Development | oligometastatic prostate cancer | Phase 2/Phase 3 | 119 | 25 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| BYLieve NCT03056755 · Novartis Pharmaceuticals DeepView → | PIK3CA-mutated HR+ HER2-negative advanced breast cancer | Phase 2 | Deep | View | |||
| PREDICT-RT NCT04513717 · NRG Oncology DeepView → | high risk prostate cancer | Phase 3 | Deep | View | |||
| PR-7 NCT00003653 · NCIC Clinical Trials Group StandardView → | prostate cancer with rising PSA after radiotherapy | Phase 3 | Standard | View | |||
| RADICALS NCT00541047 · University College, London FocusedView → | prostate cancer after radical prostatectomy | Phase 3 | Focused | View | |||
| PCS IX NCT02685397 · Sir Mortimer B. Davis - Jewish General Hospital FocusedView → | castration-resistant prostate cancer with oligometastases | Phase 2/Phase 3 | Focused | View | |||
| NCT03678025 NCT03678025 · SWOG Cancer Research Network FocusedView → | Not given | Phase 3 | Focused | View | |||
| ASCLEPIuS NCT04194554 · University of Michigan Rogel Cancer Center FocusedView → | high-risk and node-positive prostate cancer | Phase 1/Phase 2 | Focused | View | |||
| NCT03298087 NCT03298087 · VA Office of Research and Development FocusedView → | newly diagnosed oligometastatic prostate cancer | Phase 2 | Focused | View | |||
| INDICATE NCT04423211 · ECOG-ACRIN Cancer Research Group FocusedView → | Not given | Phase 3 | Focused | View | |||